Press Releases

Results found (110)
June 10, 2013
Yissum Introduces a Novel Method for Diagnosing Retinal Micro-Aneurysms to...

A novel method for detecting retinal micro-aneurysms that pose a high risk for leakage, an underlying cause of diabetic retinopathy. Diabetic retinopathy is a leading cause of blindness worldwide. The novel method will enable early diagnosis and...

March 14, 2013
Yissum Licenses to Melodea a Breakthrough Technology for Manufacturing Micro...

In parallel, Holmen, a leading manufacturer in the forest based sector, has entered into an investment and sub-licensing agreement with Melodea, by which Holmen has become one of the major shareholders in Melodea. 

February 21, 2013
Avraham Pharmaceuticals Closes an Additional Investment Round of...

The capital is intended for the on-going Phase II clinical trial of ladostigil, a novel molecule for treatment of mild cognitive impairment; interim analysis is expected in H1 2014

February 5, 2013
The Ultimate Falafel – Yissum Introduces New Chickpea Varieties with High...

Yissum, introduces new chickpea varieties, which retain high nutritional values yet exhibit improved synchronization between flowering and the rainy season to increase yield. The new varieties were developed by Professor Shahal Abbo, The Robert...

December 10, 2012
Yissum Introduces a Pioneering Vaccine Against Canine Monocytic...

Results showing the effectiveness of the vaccine in dogs were recently published in the journal Vaccine

October 31, 2012
Yissum Announces Formation of Integra Holdings, a Biopharmaceutical Holding...

Integra Holdings closes U.S. $ 7.0 million private financing

July 23, 2012
Yissum Introduces a Novel Biocontrol Method for Protecting Plants from...

Novel biocontrol agent is environmentally-friendly, non-toxic and effective for a large variety of plants

July 10, 2012
Yissum Introduces a Novel Method for Treating Cancer Based on a Protein...

The novel method uses a peptide derived from HIV to increase the sensitivity of cancer cells to radiotherapy and chemotherapy

May 17, 2012
Yissum Spin Off Avraham Pharmaceuticals Announces Commencement of a Phase 2...

Yaacov Michlin appointed Chairman of the Board and Dr. Yona Geffen appointed Chief Executive Officer

May 15, 2012
Yissum Introduces a Novel Method for Improving Fish Farming

Technology, to be presented at Agritech Israel 2012, enables better control over fish reproduction cycle, increasing spawning and fish size 

 

March 5, 2012
Yissum Yissum Signs Licensing Agreement with Dow AgroFresh for a Novel...

Yissum, the research and development company of the Hebrew University of Jerusalem, North Carolina State University, Raleigh , N.C., and Dow AgroFresh, a business unit of Rohm and Haas Company, a wholly owned subsidiary of The Dow Chemical...

December 19, 2011
Yissum Introduces a Novel Technology for Manufacturing an Anti-Malaria Drug...

The work was published in the latest issue of the prestigious Nature Biotechnology journal